Orthofix Medical (NASDAQ:OFIX) Receives Buy Rating from Canaccord Genuity Group

Canaccord Genuity Group reaffirmed their buy rating on shares of Orthofix Medical (NASDAQ:OFIX – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. Canaccord Genuity Group currently has a $24.00 target price on the medical device company’s stock. OFIX has been the subject of several other research reports. Stifel Nicolaus upgraded […]

Mar 1, 2025 - 09:45

Canaccord Genuity Group reaffirmed their buy rating on shares of Orthofix Medical (NASDAQ:OFIX – Free Report) in a research note issued to investors on Wednesday morning,Benzinga reports. Canaccord Genuity Group currently has a $24.00 target price on the medical device company’s stock. OFIX has been the subject of several other research reports. Stifel Nicolaus upgraded […]